Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: A decision-analytic and economic analysis

American Journal of Obstetrics and Gynecology

Volumn 205, Issue 6, 2011, Pages 542.e1-542.e7

  Cahill, Alison G ^a   Odibo, Anthony O ^a   Stout, Molly J ^a   Grobman, William A ^b   MacOnes, George A ^a   Caughey, Aaron B ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

cerebral palsy; magnesium; neuroprophylaxis; preterm birth

Indexed keywords

MAGNESIUM SULFATE;

CEREBRAL PALSY; CONFERENCE PAPER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG EFFICACY; ECONOMIC EVALUATION; FEMALE; GESTATIONAL AGE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MATERNAL WELFARE; MEDICAL DECISION MAKING; NEUROPROTECTION; NEWBORN DEATH; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY ADJUSTED LIFE YEAR; RISK REDUCTION; SENSITIVITY ANALYSIS; TREATMENT RESPONSE;

EID: 81855183274     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.09.004     Document Type: Conference Paper

References (48)

1. M. van de Bor, S.P. Verloove-Vanhorick, R. Brand, M.J. Keirse, and J.H. Ruys Incidence and prediction of periventricular-intraventricular hemorrhage in very preterm infants J Perinat Med 15 1987 333 339 (Pubitemid 18006116)
2. K.C. Kuban, A. Leviton, M. Pagano, T. Fenton, R. Strassfeld, and M. Wolff Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies J Child Neurol 7 1992 70 76
3. K.B. Nelson, and J.K. Grether Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 95 1995 263 269
4. R. Mittendorf, J. Dambrosia, and P.G. Pryde Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants Am J Obstet Gynecol 186 2002 1111 1118 (Pubitemid 34665044)
5. C.A. Crowther, J.E. Hiller, L.W. Doyle, and R.R. Haslam Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial JAMA 290 2003 2669 2676 (Pubitemid 37475594)
6. S. Marret, L. Marpeau, and V. Zupan-Simunek Magnesium sulphate given before very-preterm birth to protect infant brain: the randomized controlled PREMAG trial (*) BJOG 114 2007 310 318
7. D.J. Rouse, D.G. Hirtz, and E. Thom A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy N Engl J Med 359 2008 895 905
8. L.W. Doyle, C.A. Crowther, P. Middleton, S. Marret, and D. Rouse Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus Cochrane Database Syst Rev 1 2009 CD004661
9. P.A. Blasco Primitive reflexes: their contribution to the early detection of cerebral palsy Clin Pediatr (Phila) 33 1994 388 397 (Pubitemid 24225995)
10. A.J. Capute, and B.K. Shapiro The motor quotient: a method for the early detection of motor delay Am J Dis Child 139 1985 940 942 (Pubitemid 15021634)
11. R. Palisano, P. Rosenbaum, S. Walter, D. Russell, E. Wood, and B. Galuppi Development and reliability of a system to classify gross motor function in children with cerebral palsy Dev Med Child Neurol 39 1997 214 223 (Pubitemid 27226331)
12. American College of Obstetricians and Gynecologists. ACOG Committee on Practice BulletinsObstetrics ACOG practice bulletin no. 80: premature rupture of membranes; clinical management guidelines for obstetrician-gynecologists Obstet Gynecol 109 2007 1007 1019
13. J.A. Martin, K.D. Kochanek, D.M. Strobino, B. Guyer, and M.F. MacDorman Annual summary of vital statistics2003 Pediatrics 115 2005 619 634
14. D. Moster, R.T. Lie, and T. Markestad Long-term medical and social consequences of preterm birth N Engl J Med 359 2008 262 273 (Pubitemid 352008441)
15. J.M. Tucker, R.L. Goldenberg, R.O. Davis, R.L. Copper, C.L. Winkler, and J.C. Hauth Etiologies of preterm birth in an indigent population: is prevention a logical expectation? Obstet Gynecol 77 1991 343 347
16. R.L. Goldenberg, J.F. Culhane, J.D. Iams, and R. Romero Epidemiology and causes of preterm birth Lancet 371 2008 75 84
17. B.M. Mercer Preterm premature rupture of the membranes Obstet Gynecol 101 2003 178 193 (Pubitemid 36061260)
18. G.A. Macones, S.Y. Segel, D.M. Stamilio, and M.A. Morgan Prediction of delivery among women with early preterm labor by means of clinical characteristics alone Am J Obstet Gynecol 181 1999 1414 1418 (Pubitemid 30021886)
19. J.D. Iams Prediction and early detection of preterm labor Obstet Gynecol 101 2003 402 412 (Pubitemid 36170144)
20. S. Marret, L. Marpeau, and J. Benichou Benefit of magnesium sulfate given before very preterm birth to protect infant brain Pediatrics 121 2008 225 226
21. Magpie Trial Follow-Up Study Collaborative Group The Magpie trial: a randomized trial comparing magnesium sulphate with placebo for pre-eclampsia; outcome for children at 18 months BJOG 114 2007 289 299
22. D.D. McIntire, and K.J. Leveno Neonatal mortality and morbidity rates in late preterm births compared with births at term Obstet Gynecol 111 2008 35 41
23. A.C. Chau, H.A. Gabert, and J.M. Miller Jr A prospective comparison of terbutaline and magnesium for tocolysis Obstet Gynecol 80 1992 847 851
24. Y.Y. El-Sayed, E.T. Riley, R.H. Holbrook Jr, S.E. Cohen, U. Chitkara, and M.L. Druzin Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labor Obstet Gynecol 93 1999 79 83
25. J.L. Glock, and W.J. Morales Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study Am J Obstet Gynecol 169 1993 960 964 (Pubitemid 23317536)
26. J.E. Larmon, B.S. Ross, W.L. May, G.A. Dickerson, R.G. Fischer, and J.C. Morrison Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor Am J Obstet Gynecol 181 1999 1432 1437 (Pubitemid 30021889)
27. J. McWhorter, S.J. Carlan, T.D. OLeary, K. Richichi, and W.F. OBrien Rofecoxib versus magnesium sulfate to arrest preterm labor: a randomized trial Obstet Gynecol 103 2004 923 930 (Pubitemid 40458993)
28. D.A. Terrone, B.K. Rinehart, E.S. Kimmel, W.L. May, J.E. Larmon, and J.C. Morrison A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis Am J Obstet Gynecol 182 2000 1477 1482 (Pubitemid 30437419)
29. Centers for Disease Control and Prevention http://www.cdc.gov/nchs/data/ nvsr/nvsr59/nvsr59-04.pdf Accessed Aug. 10, 2011
30. E. Blair, L. Watson, N. Badawi, and F.J. Stanley Life expectancy among people with cerebral palsy in Western Australia Dev Med Child Neurol 43 2001 508 515 (Pubitemid 32743208)
31. D. Strauss, J. Brooks, L. Rosenbloom, and R. Shavelle Life expectancy in cerebral palsy: an update Dev Med Child Neurol 50 2008 487 493 (Pubitemid 351973629)
32. C.T. Pham, and C.A. Crowther Birth outcomes: utility values that postnatal women, midwives and medical staff express BJOG 110 2003 121 127 (Pubitemid 36263106)
33. F.P. Vandenbussche, L.C. De Jong-Potjer, A.M. Stiggelbout, S. Le Cessie, and M.J. Keirse Differences in the valuation of birth outcomes among pregnant women, mothers, and obstetricians Birth 26 1999 178 183
34. E. Hayes, L. Moroz, L. Pizzi, and J. Baxter A cost decision analysis of 4 tocolytic drugs Am J Obstet Gynecol 197 2007 383.e1 383.e6
35. N.J. Waitzman, P.S. Romano, and R.M. Scheffler Estimates of the economic costs of birth defects Inquiry 31 1994 188 205 (Pubitemid 24226070)
36. C.S. Phibbs, and S.K. Schmitt Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants Early Hum Dev 82 2006 85 95 (Pubitemid 43234042)
37. Medicare and Medicaid statistical supplement, 1995 US Department of Health and Human Services, Health Care Financing Administration Health Care Financ Rev Stat Suppl 1995 1 388
38. M.F. Drummond, M. Barbieri, and J.B. Wong Analytic choices in economic models of treatments for rheumatoid arthritis: what makes a difference? Med Decis Making 25 2005 520 533 (Pubitemid 41384066)
39. D.K. Owens Interpretation of cost-effectiveness analyses J Gen Intern Med 13 1998 716 717 (Pubitemid 28473801)
40. W.J. Hueston Preterm contractions in community settings, II: predicting preterm birth in women with preterm contractions Obstet Gynecol 92 1998 43 46 (Pubitemid 28285317)
41. W.J. Hueston Preterm contractions in community settings, I: treatment of preterm contractions Obstet Gynecol 92 1998 38 42 (Pubitemid 28285316)
42. J.F. King, A. Grant, M.J. Keirse, and I. Chalmers Beta-mimetics in preterm labor: an overview of the randomized controlled trials Br J Obstet Gynaecol 95 1988 211 222
43. G.A. Macones MgSO4 for CP prevention: too good to be true? Am J Obstet Gynecol 200 2009 589
44. A.G. Cahill, and A.B. Caughey Magnesium for neuroprophylaxis: fact or fiction? Am J Obstet Gynecol 200 2009 590 594
45. D.J. Rouse Magnesium sulfate for the prevention of cerebral palsy Am J Obstet Gynecol 200 2009 610 612
46. F.J. Stanley, and C. Crowther Antenatal magnesium sulfate for neuroprotection before preterm birth? N Engl J Med 359 2008 962 964
47. A. Conde-Agudelo, and R. Romero Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis Am J Obstet Gynecol 200 2009 595 609
48. American College of Obstetricians and Gynecologists Committee on Obstetric Practice; Society for Maternal-Fetal Medicine Committee opinion No. 455: magnesium sulfate before anticipated preterm birth for neuroprotection Obstet Gynecol 115 2010 669 671